A method of correcting endothelial dysfunction amlodipine and resveratrol IN L-NAME-INDUCED NITRIC OXIDE DEFICIENCY

摘要

method of correction of endothelial corneal dysfunction, including the use of u0430u043cu043bu043eu0434u0438u043fu0438u043du0430, u043eu0442u043du043eu0441u00a0u0449u0435u0433u043eu0441u00a0 to u0430u043du0442u0430u0433u043eu043du0438u0441u0442u0430u043c u043au0430u043bu044cu0446u0438u00a0 u0434u0438u0433u0438u0434u0440u043eu043fu0438u0440u0438u0434u0438u043du043eu0432u043eu0433u043e u0440u00a0u0434u0430, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 those m, the pilot laboratory animal with endothelial corneal dysfunction, against the background of its u043cu043eu0434u0435u043bu0438u0440u043eu0432u0430u043du0438u00a0 u0432u0432u043eu0434u00a0u0442 u0432u043du0443u0442u0440u0438u0436u0435u043bu0443u0434u043eu0447u043du043e amlodipine in a dose of 0.5 mg / kg and u0432u043du0443u0442u0440u0438u0431u0440u044eu0448 innovation u0440u0435u0437u0432u0435u0440u0430u0442u0440u043eu043b in a dose of 2 mg / kg, once a day.